More than 60% of pharmaceuticals are related to natural products (NPs), chemicals produced by living organisms. 1 Hence, new methods that accelerate natural product discovery are poised to profoundly impact human health. Of the many challenges that remain in natural product discovery, none are as pervasive as structural elucidation, as determination of the molecular structure of a newly discovered natural product can take months, years, or in some cases be altogether unachievable. This challenge can be fueled by lack of sufficient material for spectroscopic analysis, or difficulties in sourcing the producing organism. 2 Even in cases where the analyte is abundant, its physical properties, including molecular structure, can prevent unambiguous structural determination. 3,4 Here we report the use of microcrystal electron diffraction (MicroED), 5 an emerging cryogenic electron microscopy (CryoEM) technique, in combination with genome mining 6 to address these challenges. As proof-of-principle, we apply these techniques to fischerin (1), an orphan NP isolated more than 30 years ago, with potent